Product Name: p70S6K (128-153)
Product Number: PE-01AQP75
Size: 1 mg      Price:43.00
5 mg      $US118.00
20 mg      245.00
Peptide Name: p70S6K (128-153)

Product Use: Services as a blocking peptide for use with the S6K-III rabbit polyclonal antibody (Cat. No.: AB-NK223-4) that is also available from Kinexus. The peptide sequence is located in the kinase catalytic subdomain 3.

Peptide Production Method: Solid-phase peptide synthesis

Peptide Origin: Homo sapiens

Peptide Sequence: AMIVRNAKDTAHTKAERNILEEVKHP-GGC

Peptide Modifications N Terminus: Free amino

Peptide Modifications C Terminus: Amide

Peptide Molecular Mass Calculated: 3188.57 Da

Peptide Purity Percent after Synthesis and Purification: >50
Peptide Appearance: White powder

Peptide Form: Solid

Storage Conditions: -20°C

Related Product 1: p70S6K pan-specific antibody (Cat. No.: AB-NK223-4)

Scientific Background: p70S6K (RPS6KB1) is a protein-serine/threonine kinase that is a member of the AGC group of protein kinases in the RSK family, and p70 subfamily. This kinase is highly expressed and widely distributed in most tested human tissues except in the brain and spinal cord where it is more moderately expressed. It functions downstream of mTOR (FRAP1) signalling in response to growth factors to promote cell proliferation, growth, and progression through the cell cycle. p70S6K is activated by phosphorylation at T252 (by PDK1), S394 (by mTOR), T412 (by mTOR), S427, S434 (by ERK1/2), S441, T444 (by ERK1/2) and S447 (by ERK1/2). p70S6K is responsible for the phosphorylation of 40S ribosomal protein S6. It is activated by serum stimulation and this activation is inhibited by wortmannin and rapamycin. p70S6K phosphotransferase activity changes during the cell cycle, and increases 20-fold in G1 cells released from G0. It has been linked with the development of diet-induced obesity, colon adenocarcinoma and breast cancer.